With regard to PSA levels, Azab et al. [4] reported that of their 142 patients treated with antibiotic and NSAIDs for 6 weeks, prostate cancer was detected in 12% (three of 25 patients) with PSA levels of < 2.5 ng/mL, 12.7% (six of 47 patients) with PSA levels of ≥ 2.5–< 4.0 ng/mL, and in 30% (21/70 patients) with PSA levels ≥ 4.0 ng/mL. Here, KLK3 is linked to prostate carcinoma.